Trifluridine in Resistant Human Herpetic Keratitis
- 1 October 1978
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 96 (10) , 1839-1841
- https://doi.org/10.1001/archopht.1978.03910060351011
Abstract
• Patients with active dendritic herpetic keratitis that was unresponsive to topical idoxuridine or vidarabine therapy were treated topically with a 1% solution of trifluridine. The dendritic ulcers healed in an average time of 6.1 days. All patients tolerated the drug well except for one patient in whom a reversible crystalline epithelial keratitis developed.This publication has 6 references indexed in Scilit:
- Treatment of Vaccinial Keratitis With TrifluorothymidineArchives of Ophthalmology (1950), 1976
- Current and proposed management of ocular herpes simplexSurvey of Ophthalmology, 1976
- Newer Compounds in Therapy of Herpes Simplex KeratitisArchives of Ophthalmology (1950), 1967
- STUDIES ON HERPES SIMPLEX .11. ANTIVIRAL DYNAMICS OF 5-IODO-2-DEOXYURIDINE IN VIVO1965
- Therapeutic Antiviral Action of 5-Trifluoromethyl-2′-deoxyuridine in Herpes Simplex KeratitisScience, 1964
- IDU Therapy of Herpes SimplexArchives of Ophthalmology (1950), 1962